第一届国际医学影像临床应用与学术论著发表策略研讨会圆满落下帷幕

2011-03-28 MedSci MedSci原创

生物谷Bioon.com 上海讯 2011年3月27日12:30 为期一天半的首届国际医学影像临床应用与学术论著发表策略研讨会圆满落下帷幕。此次大会获得复旦大学生物医学研究所的大力支持。24小时医学频道、爱爱医、中国医药报、中国数字医疗网及生物谷等媒体支持了本次大会,研讨会吸引了二百名来自全国各地乃至国外从业人员的参加。 (研讨会现场 生物谷Bioon.com 摄) (影像学国际顶级杂志主

生物谷Bioon.com 上海讯 2011年3月27日12:30 为期一天半的首届国际医学影像临床应用与学术论著发表策略研讨会圆满落下帷幕。此次大会获得复旦大学生物医学研究所的大力支持。24小时医学频道、爱爱医、中国医药报、中国数字医疗网及生物谷等媒体支持了本次大会,研讨会吸引了二百名来自全国各地乃至国外从业人员的参加。


(研讨会现场 生物谷Bioon.com 摄)


(影像学国际顶级杂志主编M.Schweitzer博士(左)、Thomas Dierks(右)现场指导 生物谷Bioon.com 摄)


(李明华教授(左)、程英升教授(中)、姚晨教授(右)精彩演讲 生物谷Bioon.com 摄)

会议期间共有六位嘉宾作精彩报告,研讨会就当前医学影像学的最新进展入手,结合国际顶级学术期刊杂志Radiology、Neuroimaging主编多年的编审稿经验、MedSci科学家SCI论文选题和写作技巧以及北京大学、上海十院等专家学者的切身经验,为广大参会把握医学影像领域国际最新进展与发展趋势,加强临床科研立题方法和技巧、学术论著发表策略,以及医学影像领域基金申请技巧提供了宝贵经验。

另外,此次研讨会组委会请国内外资深专家对会前投稿的文章进行质量快速评审,并当面进行了"1对1"点评。


(嘉宾与参会代表现场沟通 生物谷Bioon.com 摄)


(专家现场1对1 生物谷Bioon.com 摄)

本次研讨会由MedSci主办。凭借独特学术背景和技术优势为客户提供专业的"一站式"科研学术服务的MedSci,多年来,一直专注于医学生物学领域,已服务70多个细分学科的20000多名客户,成功协助他们开展科学研究,并帮助其在第一时间将临床发现与科研成果展现给世界的同行们。(生物谷 Bioon.com)

相关阅读

高端的医学影像 不对称的人才结构
医学影像临床应用发展趋势 影像新技术给力SCI论文发表

更多内容请点击进入此次会议专题网站
https://www.medsci.cn/z/rad-sci/

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1835545, encodeId=d5d818355450d, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Tue Aug 02 11:46:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994649, encodeId=79fb1994649af, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sat Nov 26 22:46:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2762, encodeId=40732e6284, content=与我们研究有些关系,以后多加关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=914843917, createdName=gracekxy, createdTime=Tue Aug 16 12:26:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812907, encodeId=91aa181290e84, content=<a href='/topic/show?id=d56891420f2' target=_blank style='color:#2F92EE;'>#论著#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91420, encryptionId=d56891420f2, topicName=论著)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jul 21 20:46:00 CST 2011, time=2011-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110, encodeId=7f9f211095, content=可惜可惜,不知道消息,否则一定来参加了。不知有没有会议资料?, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=郑春久, createdTime=Sat Apr 02 12:42:00 CST 2011, time=2011-04-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1835545, encodeId=d5d818355450d, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Tue Aug 02 11:46:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994649, encodeId=79fb1994649af, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sat Nov 26 22:46:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2762, encodeId=40732e6284, content=与我们研究有些关系,以后多加关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=914843917, createdName=gracekxy, createdTime=Tue Aug 16 12:26:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812907, encodeId=91aa181290e84, content=<a href='/topic/show?id=d56891420f2' target=_blank style='color:#2F92EE;'>#论著#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91420, encryptionId=d56891420f2, topicName=论著)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jul 21 20:46:00 CST 2011, time=2011-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110, encodeId=7f9f211095, content=可惜可惜,不知道消息,否则一定来参加了。不知有没有会议资料?, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=郑春久, createdTime=Sat Apr 02 12:42:00 CST 2011, time=2011-04-02, status=1, ipAttribution=)]
    2011-11-26 kcb069
  3. [GetPortalCommentsPageByObjectIdResponse(id=1835545, encodeId=d5d818355450d, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Tue Aug 02 11:46:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994649, encodeId=79fb1994649af, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sat Nov 26 22:46:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2762, encodeId=40732e6284, content=与我们研究有些关系,以后多加关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=914843917, createdName=gracekxy, createdTime=Tue Aug 16 12:26:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812907, encodeId=91aa181290e84, content=<a href='/topic/show?id=d56891420f2' target=_blank style='color:#2F92EE;'>#论著#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91420, encryptionId=d56891420f2, topicName=论著)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jul 21 20:46:00 CST 2011, time=2011-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110, encodeId=7f9f211095, content=可惜可惜,不知道消息,否则一定来参加了。不知有没有会议资料?, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=郑春久, createdTime=Sat Apr 02 12:42:00 CST 2011, time=2011-04-02, status=1, ipAttribution=)]
    2011-08-16 gracekxy

    与我们研究有些关系,以后多加关注!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1835545, encodeId=d5d818355450d, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Tue Aug 02 11:46:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994649, encodeId=79fb1994649af, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sat Nov 26 22:46:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2762, encodeId=40732e6284, content=与我们研究有些关系,以后多加关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=914843917, createdName=gracekxy, createdTime=Tue Aug 16 12:26:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812907, encodeId=91aa181290e84, content=<a href='/topic/show?id=d56891420f2' target=_blank style='color:#2F92EE;'>#论著#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91420, encryptionId=d56891420f2, topicName=论著)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jul 21 20:46:00 CST 2011, time=2011-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110, encodeId=7f9f211095, content=可惜可惜,不知道消息,否则一定来参加了。不知有没有会议资料?, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=郑春久, createdTime=Sat Apr 02 12:42:00 CST 2011, time=2011-04-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1835545, encodeId=d5d818355450d, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Tue Aug 02 11:46:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994649, encodeId=79fb1994649af, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sat Nov 26 22:46:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2762, encodeId=40732e6284, content=与我们研究有些关系,以后多加关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=914843917, createdName=gracekxy, createdTime=Tue Aug 16 12:26:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812907, encodeId=91aa181290e84, content=<a href='/topic/show?id=d56891420f2' target=_blank style='color:#2F92EE;'>#论著#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91420, encryptionId=d56891420f2, topicName=论著)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jul 21 20:46:00 CST 2011, time=2011-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110, encodeId=7f9f211095, content=可惜可惜,不知道消息,否则一定来参加了。不知有没有会议资料?, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=郑春久, createdTime=Sat Apr 02 12:42:00 CST 2011, time=2011-04-02, status=1, ipAttribution=)]
    2011-04-02 郑春久

    可惜可惜,不知道消息,否则一定来参加了。不知有没有会议资料?

    0

相关资讯

MedSci“临床科研中国行”全国巡回讲座(济南站)圆满落幕

         MedSci“临床科研中国行”全国巡回讲座(济南站)于2010年12月22日在山东省立医院圆满落幕,本次讲座的主要内容有:1. 临床资料如何转化成SCI文章; 2. 医学SCI论文写作技巧;3. 基金写作与申请技巧。讲座吸引了大批MedSci新老客户的参与,MedSci资深编辑将MedSci处理过的数

MedSci“临床科研中国行”全国巡回讲座(武汉站)圆满落幕

        MedSci“临床科研中国行”全国巡回讲座(武汉站)于2010年11月26日圆满落幕,本次讲座的主要内容有:1. 临床资料如何转化成SCI文章; 2. SCI论文发表支持与期刊选择技巧;3. 从REVIEWER角度看SCI文章。讲座吸引了大批MedSci新老客户的参与,MedSci资深编辑将MedSci处理过的数

MedSci参加“中华医学会糖尿病学分会第十四次全国学术会议”

        2010年11月20日,由中华医学会、中华医学会糖尿病学分会主办的“中华医学会糖尿病学分会第十四次全国学术会议”于苏州国际博览中心落下帷幕。此次论坛吸引到近4000名国内外相关人士参加,并就相关问题进行了深入交流和讨论。        

热烈庆祝MedSci乔迁新居

尊敬的老师,您好:         感谢您一直以来对MedSci的信任和支持!         MedSci经过多年的成长与积累,持续发展壮大,近期由于公司发展的需要,公司总部将于2010年11月月底乔迁新址:上海市徐汇区中山西路2020号(宜山

MedSci“临床科研中国行”全国巡回讲座(南京军区南京总医院)圆满落幕

        MedSci“临床科研中国行”全国巡回讲座(南京军区南京总医院讲座)已于2010年10月23日圆满落幕。本次讲座的主要内容有:1. SCI论文设计及写作注意事项; 2. SCI论文发表支持及常见问题分析。讲座吸引了大批MedSci新老客户的参与,MedSci资深编辑将MedSci处理过的数万篇中国论文的宝贵经验,

预告:MedSci“临床科研中国行”全国巡回讲座(济南站)

        MedSci是综合临床医学和科研学术服务平台,致力于从事医学临床和科研的教育、培训和医学学术服务指导,全面提升中国医学和科研学术水平,全面对接中国和国际最新研究成果。        MedSci将于12月底在济南地区举办医学临床科研讲座,Med